Associations between endothelial cell activation and acute GVHD after allogeneic hematopoietic stem cell transplantation

Shosaku Nomura, Kazuyoshi Ishii, Yoshinobu Maeda, Yuta Katayama, Hideo Yagi, Naohito Fujishima, Shuichi Ota, Masato Moriyama, Masanori Seki, Masaya Okada, Yasuhiko Miyazaki, Yoshio Saburi, Eitoh Boku, Takayuki Ikezoe, Kunio Hayashi, Nobuyoshi Arima, Shinya Fujita, Aya Nakaya, Atsushi Satake, Tomoki Ito & 7 others Masanori Matsumoto, Taiichi Kyo, Yoji Ishida, Shigeru Chiba, Hiroyasu Ogawa, Mitsune Tanimoto, Kenichi Sawada

Research output: Contribution to journalArticle

Abstract

Hematopoietic stem cell transplantation (HSCT) involves the potential for certain serious transplantrelated complications such as graft-versus-host disease (GVHD), and recovery from such complications is vital for a successful HSCT outcome. Acute GVHD (aGVHD) occurs in the early period after transplantation and is initiated by alloreactive donor T cells. The mechanisms whereby immune responses trigger this post-transplantation condition remain unclear, but endothelial cell function might play a role in this. We investigated the expression of endothelial cell activation markers such as sE-selectin, sVCAM-1, PAI-1 and microparticle (MP) in patients undergoing allogeneic HSCT. Additionally, we studied the effects of recombinant soluble thrombomodulin (rTM) on the expression of these markers. Our study cohort included 312 patients who underwent allo HSCT at 25 institutions in Japan. In the 143 patients who developed aGVHD, levels of endothelial cell activation markers were significantly higher compared to patients who did not develop aGVHD. Moreover, patients who received rTM exhibited a significantly lower frequency of aGVHD and reduced levels of endothelial cell activation markers. Our findings suggest that endothelial cell activation might be linked to aGVHD, and that rTM might at least in part act to prevent aGVHD by its effect on endothelial cells.

Original languageEnglish
Pages (from-to)17-25
Number of pages9
JournalCurrent Trends in Immunology
Volume16
Publication statusPublished - Jan 1 2015

Fingerprint

Hematopoietic Stem Cell Transplantation
Graft vs Host Disease
Endothelial Cells
Thrombomodulin
Transplantation
Selectins
Plasminogen Activator Inhibitor 1
Japan
Cohort Studies
Tissue Donors
T-Lymphocytes

Keywords

  • HMGB1
  • RTM
  • SE-selectin
  • Stem cell transplantation
  • TAC

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Associations between endothelial cell activation and acute GVHD after allogeneic hematopoietic stem cell transplantation. / Nomura, Shosaku; Ishii, Kazuyoshi; Maeda, Yoshinobu; Katayama, Yuta; Yagi, Hideo; Fujishima, Naohito; Ota, Shuichi; Moriyama, Masato; Seki, Masanori; Okada, Masaya; Miyazaki, Yasuhiko; Saburi, Yoshio; Boku, Eitoh; Ikezoe, Takayuki; Hayashi, Kunio; Arima, Nobuyoshi; Fujita, Shinya; Nakaya, Aya; Satake, Atsushi; Ito, Tomoki; Matsumoto, Masanori; Kyo, Taiichi; Ishida, Yoji; Chiba, Shigeru; Ogawa, Hiroyasu; Tanimoto, Mitsune; Sawada, Kenichi.

In: Current Trends in Immunology, Vol. 16, 01.01.2015, p. 17-25.

Research output: Contribution to journalArticle

Nomura, S, Ishii, K, Maeda, Y, Katayama, Y, Yagi, H, Fujishima, N, Ota, S, Moriyama, M, Seki, M, Okada, M, Miyazaki, Y, Saburi, Y, Boku, E, Ikezoe, T, Hayashi, K, Arima, N, Fujita, S, Nakaya, A, Satake, A, Ito, T, Matsumoto, M, Kyo, T, Ishida, Y, Chiba, S, Ogawa, H, Tanimoto, M & Sawada, K 2015, 'Associations between endothelial cell activation and acute GVHD after allogeneic hematopoietic stem cell transplantation', Current Trends in Immunology, vol. 16, pp. 17-25.
Nomura, Shosaku ; Ishii, Kazuyoshi ; Maeda, Yoshinobu ; Katayama, Yuta ; Yagi, Hideo ; Fujishima, Naohito ; Ota, Shuichi ; Moriyama, Masato ; Seki, Masanori ; Okada, Masaya ; Miyazaki, Yasuhiko ; Saburi, Yoshio ; Boku, Eitoh ; Ikezoe, Takayuki ; Hayashi, Kunio ; Arima, Nobuyoshi ; Fujita, Shinya ; Nakaya, Aya ; Satake, Atsushi ; Ito, Tomoki ; Matsumoto, Masanori ; Kyo, Taiichi ; Ishida, Yoji ; Chiba, Shigeru ; Ogawa, Hiroyasu ; Tanimoto, Mitsune ; Sawada, Kenichi. / Associations between endothelial cell activation and acute GVHD after allogeneic hematopoietic stem cell transplantation. In: Current Trends in Immunology. 2015 ; Vol. 16. pp. 17-25.
@article{845a89e723564de190c4e2cc81e3ffc3,
title = "Associations between endothelial cell activation and acute GVHD after allogeneic hematopoietic stem cell transplantation",
abstract = "Hematopoietic stem cell transplantation (HSCT) involves the potential for certain serious transplantrelated complications such as graft-versus-host disease (GVHD), and recovery from such complications is vital for a successful HSCT outcome. Acute GVHD (aGVHD) occurs in the early period after transplantation and is initiated by alloreactive donor T cells. The mechanisms whereby immune responses trigger this post-transplantation condition remain unclear, but endothelial cell function might play a role in this. We investigated the expression of endothelial cell activation markers such as sE-selectin, sVCAM-1, PAI-1 and microparticle (MP) in patients undergoing allogeneic HSCT. Additionally, we studied the effects of recombinant soluble thrombomodulin (rTM) on the expression of these markers. Our study cohort included 312 patients who underwent allo HSCT at 25 institutions in Japan. In the 143 patients who developed aGVHD, levels of endothelial cell activation markers were significantly higher compared to patients who did not develop aGVHD. Moreover, patients who received rTM exhibited a significantly lower frequency of aGVHD and reduced levels of endothelial cell activation markers. Our findings suggest that endothelial cell activation might be linked to aGVHD, and that rTM might at least in part act to prevent aGVHD by its effect on endothelial cells.",
keywords = "HMGB1, RTM, SE-selectin, Stem cell transplantation, TAC",
author = "Shosaku Nomura and Kazuyoshi Ishii and Yoshinobu Maeda and Yuta Katayama and Hideo Yagi and Naohito Fujishima and Shuichi Ota and Masato Moriyama and Masanori Seki and Masaya Okada and Yasuhiko Miyazaki and Yoshio Saburi and Eitoh Boku and Takayuki Ikezoe and Kunio Hayashi and Nobuyoshi Arima and Shinya Fujita and Aya Nakaya and Atsushi Satake and Tomoki Ito and Masanori Matsumoto and Taiichi Kyo and Yoji Ishida and Shigeru Chiba and Hiroyasu Ogawa and Mitsune Tanimoto and Kenichi Sawada",
year = "2015",
month = "1",
day = "1",
language = "English",
volume = "16",
pages = "17--25",
journal = "Current Trends in Immunology",
issn = "0972-4567",
publisher = "Research Trends",

}

TY - JOUR

T1 - Associations between endothelial cell activation and acute GVHD after allogeneic hematopoietic stem cell transplantation

AU - Nomura, Shosaku

AU - Ishii, Kazuyoshi

AU - Maeda, Yoshinobu

AU - Katayama, Yuta

AU - Yagi, Hideo

AU - Fujishima, Naohito

AU - Ota, Shuichi

AU - Moriyama, Masato

AU - Seki, Masanori

AU - Okada, Masaya

AU - Miyazaki, Yasuhiko

AU - Saburi, Yoshio

AU - Boku, Eitoh

AU - Ikezoe, Takayuki

AU - Hayashi, Kunio

AU - Arima, Nobuyoshi

AU - Fujita, Shinya

AU - Nakaya, Aya

AU - Satake, Atsushi

AU - Ito, Tomoki

AU - Matsumoto, Masanori

AU - Kyo, Taiichi

AU - Ishida, Yoji

AU - Chiba, Shigeru

AU - Ogawa, Hiroyasu

AU - Tanimoto, Mitsune

AU - Sawada, Kenichi

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Hematopoietic stem cell transplantation (HSCT) involves the potential for certain serious transplantrelated complications such as graft-versus-host disease (GVHD), and recovery from such complications is vital for a successful HSCT outcome. Acute GVHD (aGVHD) occurs in the early period after transplantation and is initiated by alloreactive donor T cells. The mechanisms whereby immune responses trigger this post-transplantation condition remain unclear, but endothelial cell function might play a role in this. We investigated the expression of endothelial cell activation markers such as sE-selectin, sVCAM-1, PAI-1 and microparticle (MP) in patients undergoing allogeneic HSCT. Additionally, we studied the effects of recombinant soluble thrombomodulin (rTM) on the expression of these markers. Our study cohort included 312 patients who underwent allo HSCT at 25 institutions in Japan. In the 143 patients who developed aGVHD, levels of endothelial cell activation markers were significantly higher compared to patients who did not develop aGVHD. Moreover, patients who received rTM exhibited a significantly lower frequency of aGVHD and reduced levels of endothelial cell activation markers. Our findings suggest that endothelial cell activation might be linked to aGVHD, and that rTM might at least in part act to prevent aGVHD by its effect on endothelial cells.

AB - Hematopoietic stem cell transplantation (HSCT) involves the potential for certain serious transplantrelated complications such as graft-versus-host disease (GVHD), and recovery from such complications is vital for a successful HSCT outcome. Acute GVHD (aGVHD) occurs in the early period after transplantation and is initiated by alloreactive donor T cells. The mechanisms whereby immune responses trigger this post-transplantation condition remain unclear, but endothelial cell function might play a role in this. We investigated the expression of endothelial cell activation markers such as sE-selectin, sVCAM-1, PAI-1 and microparticle (MP) in patients undergoing allogeneic HSCT. Additionally, we studied the effects of recombinant soluble thrombomodulin (rTM) on the expression of these markers. Our study cohort included 312 patients who underwent allo HSCT at 25 institutions in Japan. In the 143 patients who developed aGVHD, levels of endothelial cell activation markers were significantly higher compared to patients who did not develop aGVHD. Moreover, patients who received rTM exhibited a significantly lower frequency of aGVHD and reduced levels of endothelial cell activation markers. Our findings suggest that endothelial cell activation might be linked to aGVHD, and that rTM might at least in part act to prevent aGVHD by its effect on endothelial cells.

KW - HMGB1

KW - RTM

KW - SE-selectin

KW - Stem cell transplantation

KW - TAC

UR - http://www.scopus.com/inward/record.url?scp=85041533170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041533170&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 17

EP - 25

JO - Current Trends in Immunology

JF - Current Trends in Immunology

SN - 0972-4567

ER -